000 03405nam a22004335i 4500
999 _c368069
_d368069
_x1
001 368069
003 ES-MaUEC
005 20230102121704.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 220211s2022 si | s |||| 0|eng d
020 _a9789811660924
024 7 _a10.1007/978-981-16-6092-4
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRA1211
_b2022 EB
100 _aChidambaram, Saravana Babu
_eautor
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_9683524
245 0 0 _aIntroduction to Toxicological Screening Methods and Good Laboratory Practice
_cby Saravana Babu Chidambaram, M. Mohamed Essa, M. Walid Qoronfleh.
250 _aFirst edition 2022
264 1 _aSingapore
_bSpringer International Publishing
_c2022
300 _a1 recurso en línea (XX, 189 páginas)
_b1 ilustraciones
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aarchivo de texto
_bPDF
505 0 _aChapter 1. Introduction to Toxicology -- Chapter 2. Laboratory Animal models -- Chapter 3. Toxicology Screening Methods -- Chapter 4. Toxicokinetics -- Chapter 5. Safety Pharmacology -- Chapter 6. Good Laboratory Practice.
520 _aThis book focuses on the principles, methods, and interpretation involved in establishing the safety, risk, and hazard assessment of small molecules. It presents the regulatory requirements for risk and hazard identification as per the guidelines of the Organization for Economic Cooperation and Development (OECD), Paris, and the International Council for Harmonisation (ICH) of Technical Requirements for Pharmaceuticals for Human Use ICH and Schedule 'Y', India. It serves as reference material for undergraduate and postgraduate pharmacy degree students as well as senior researchers to learn about the principles, methods, and interpretations of systemic dosage (acute and repeated dose) and genotoxicity (in vitro and in vivo), special toxicological investigations such as reproductive and developmental toxicology, carcinogenicity, and toxicokinetics using animal models or in vitro methods, as applicable. This book is the first of its kind in providing information on the principles and methods of implementation of Good Laboratory Practice based on the guidelines of OECD. It includes detailed chapters about the regulatory requirements and guidelines in pharmaceutical products and agrochemicals. It also describes the infrastructure needed for preclinical studies, including in vivo and in vitro facilities.
988 _aSpringer_BiomedLife_2022
650 7 _2embne
_9140328
_aToxicología
700 1 _aEssa, M. Mohamed
_eautor
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_998418
700 _aQoronfleh, M. Walid
_eautor
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_9683525
776 0 8 _iPrinted edition:
_z9789811660917
776 0 8 _iPrinted edition:
_z9789811660931
776 0 8 _iPrinted edition:
_z9789811660948
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-16-6092-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0
998 _b04/2022
_dz
_ep
_zSI